Last reviewed · How we verify

NCT05118191

Efficacy of Commercially Available Technology in Augmenting Sleep and Well-being

Completed NA Last updated 8 March 2024
What this trial tests

NA trial testing OOLER in Sleep Quality in 52 participants. Completed in 30 October 2023.

Timeline
18 October 2021
Primary endpoint
10 November 2022
30 October 2023

Quick facts

Lead sponsorWest Virginia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment52
Start date18 October 2021
Primary completion10 November 2022
Estimated completion30 October 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

West Virginia University

Who can join

Adults 18 to 50, any sex, with Sleep Quality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this research study is to assess how the implementation of various commercially available devices affect sleep quality, sleep structure, nocturnal physiology, subjective wellness, recovery from stressors, and resultant effects on performance and well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Quality

Currently open trials in the same condition.

Other West Virginia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05118191.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing